Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
N. Fintelman-Rodrigues, C. Q. Sacramento, C. Ribeiro Lima, F. Souza da Silva, A. Ferreira, M. Mattos, C. S. de Freitas, V. Cardoso Soares, S. da Silva Gomes Dias, J. R. Temerozo, M. Miranda, A. R. Matos, F. A. Bozza, N. Carels, C. Roberto Alves, , T. M. L. Souza
This study shows that atazanavir inhibits SARS-CoV-2 replication and reduces pro-inflammatory cytokine production in vitro.
Antimicrobial Agents and Chemotherapy · Sep 21, 2020Peer-reviewedMicrobiology